A single dose of eculizumab terminated life-threatening haemolysis in idiopathic IgM-mediated warm autoimmune haemolytic anaemia: A case report

Br J Haematol. 2022 Apr;197(2):e28-e31. doi: 10.1111/bjh.18011. Epub 2022 Jan 6.
No abstract available

Keywords: autoimmune haemolytic anaemia (AIHA); complement inhibitors; eculizumab; immunoglobulin M (IgM)-mediated warm AIHA.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Hemolytic, Autoimmune* / drug therapy
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Hemolysis
  • Humans
  • Immunoglobulin M

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin M
  • eculizumab